Trademark: 87323903
Word
TANVEX PHARMACEUTICALS
Status
Registered
Status Code
700
Status Date
Tuesday, May 25, 2021
Serial Number
87323903
Registration Number
6358664
Registration Date
Tuesday, May 25, 2021
Mark Type
4000
Filing Date
Friday, February 3, 2017
Published for Opposition
Tuesday, March 9, 2021

Trademark Owner History
Tanvex BioPharma, Inc. - Original Registrant

Classifications
5 Anti-arthritis preparations; anti-inflammatory agent; anticancer drug; antirheumatic preparations; medicines for human purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; western medicines for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; medicinal agent for human use, namely, medicinal herbal preparations; biological preparations for medical purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; haematogen, namely, blood substitutes for human use; chemical preparations for medical purposes for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; pharmaceutical drugs for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome; pharmaceutical preparations for treating diseases and medical conditions in the fields of dermatology, gastroenterology, hematology, infectious disease, oncology, and rheumatology, namely, neutropenia, breast cancer, gastric cancer, colorectal cancer, lung cancer, glioblastoma, carcinoma, arthritis, Crohn's disease, plaque psoriasis, asthma, chronic idiopathic urticaria, pararoxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome
"PHARMACEUTICALS"

Trademark Events
May 25, 2021
Registered-Principal Register
Mar 9, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 9, 2021
Published For Opposition
Feb 17, 2021
Notification Of Notice Of Publication E-Mailed
Feb 3, 2021
Case Returned To Examination
Jan 4, 2021
Notice Of Allowance Cancelled
Feb 2, 2021
Attorney Review/Decision On Amendment Required
Jan 4, 2021
Assigned To Petition Staff
Jan 4, 2021
Petition To Director - Change Basis - Granted
Dec 18, 2020
Teas Change Of Correspondence Received
Dec 18, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 18, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 18, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 18, 2020
Teas Petition To Amend Basis Received
Jul 23, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 22, 2020
Extension 5 Granted
Jul 1, 2020
Extension 5 Filed
Jul 22, 2020
Case Assigned To Intent To Use Paralegal
Jul 1, 2020
Teas Extension Received
Jul 1, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 1, 2020
Teas Change Of Correspondence Received
Jul 1, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Jul 1, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 1, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 1, 2020
Teas Change Of Owner Address Received
Dec 31, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 27, 2019
Extension 4 Granted
Dec 27, 2019
Extension 4 Filed
Dec 27, 2019
Teas Extension Received
Jul 8, 2019
Assigned To Examiner
Jun 7, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 5, 2019
Extension 3 Granted
Jun 5, 2019
Extension 3 Filed
Jun 5, 2019
Teas Extension Received
Dec 26, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 24, 2018
Extension 2 Granted
Dec 24, 2018
Extension 2 Filed
Dec 24, 2018
Teas Extension Received
May 4, 2018
Notice Of Approval Of Extension Request E-Mailed
May 2, 2018
Extension 1 Granted
May 2, 2018
Extension 1 Filed
May 2, 2018
Teas Extension Received
May 2, 2018
Teas Change Of Correspondence Received
Jan 2, 2018
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2017
Published For Opposition
Oct 18, 2017
Notification Of Notice Of Publication E-Mailed
Oct 5, 2017
Law Office Publication Review Completed
Oct 2, 2017
Approved For Pub - Principal Register
Sep 23, 2017
Teas/Email Correspondence Entered
Sep 23, 2017
Correspondence Received In Law Office
Sep 20, 2017
Teas Response To Office Action Received
May 6, 2017
Notification Of Priority Action E-Mailed
May 6, 2017
Priority Action E-Mailed
May 6, 2017
Priority Action Written
Apr 29, 2017
Assigned To Examiner
Mar 30, 2017
Preliminary/Voluntary Amendment - Entered
Mar 10, 2017
Assigned To Lie
Feb 23, 2017
Teas Voluntary Amendment Received
Feb 8, 2017
New Application Office Supplied Data Entered In Tram
Feb 7, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24